NCT06658496Recruiting

PDA for Kidneys Study

University of Wisconsin, Madison

Start Date

12/19/2024

Completion Date

5/1/2027

Summary

The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * Delivered at \<32 weeks' gestation * ≤72 hours of age * Inpatient at Meriter Hospital, Inc. NICU * At least one parent/guardian is able to provide parental permission in English or Spanish Exclusion Criteria: * Major congenital anomalies of kidney * Attending physician's discretion to not place NIRS sensors due to clinical concerns * In the PI or Co-I's medical opinion, there is a significant likelihood that the neonate would not survive the first 3 days of life * Birth parent aged \<18

Interventions

DEVICE

Near Infrared Spectroscopy

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Patent Ductus ArteriosusCongenital Heart Disease

Locations

Meriter Hospital, Inc.

Madison, Wisconsin 53715

United States